Who invested in Neukio Biotherapeutics?
Neukio Biotherapeutics's investors include IDG Capital, Lilly Asia Ventures and Sherpa Healthcare Partners.

Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2022, from 1 source
Neukio Biotherapeutics's investors include IDG Capital, Lilly Asia Ventures and Sherpa Healthcare Partners.
Neukio Biotherapeutics has raised $50M across 1 round since 2022.
Neukio Biotherapeutics's most recent round was a Series A of $50M in Sept 2022.
Its most recent round, $50M in Sept 2022, is also its largest on record.
Neukio Biotherapeutics's first round on record, in Sept 2022, was backed by IDG Capital, Lilly Asia Ventures and Sherpa Healthcare Partners.
Neukio Biotherapeutics's latest named round is a Series A, in Sept 2022.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.